Chronic allograft injury: Mechanisms and potential treatment targets

Transplant Rev (Orlando). 2017 Jan;31(1):1-9. doi: 10.1016/j.trre.2016.10.005. Epub 2016 Oct 11.

Abstract

Improving long-term graft survival remains one of the critical challenges facing kidney transplantation since a great portion of kidney grafts are lost by 10years after transplantation. Understanding the causes of chronic allograft injury and providing timely therapeutic interventions are essential for improving these outcomes. In this review, we will discuss the recent data that emerged turning down calcineurin inhibitors as the primary cause of long-term graft injury and highlighting the increased importance of non-compliance, antibody-mediated injury, disease recurrence, and BK nephropathy as culprits. We suggest a number of different strategies to better manage kidney transplant recipients that, ultimately, may improve long-term graft survival.

Publication types

  • Review

MeSH terms

  • Allografts
  • Biopsy, Needle
  • Chronic Disease
  • Female
  • Follow-Up Studies
  • Graft Rejection
  • Graft Survival
  • Humans
  • Immunohistochemistry
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / adverse effects
  • Kidney Transplantation / methods*
  • Male
  • Risk Assessment
  • Time Factors
  • Tissue Donors*
  • Transplantation Immunology / drug effects*
  • Transplantation, Homologous

Substances

  • Immunosuppressive Agents